7 - Metabolic Stress in Cancer, Cachexia Flashcards
Cachexia
- “Wasting Syndrome”
- Unintentional loss of body weight / mass
- Loss of appetite / energy
- Unrelated to tumor size or state
- Small Tumors of Pancreas –> MORE wasting
Cancer Associated Cachexia
CAC
-
CAC
- -> Reduce the # of CHEMOTHERAPY cycles that can be completed
- Increase complications w/ cancer
- Common at the end of life in cancer patients
Cytokine - TNF-alpha in Cachexia
- One cytokine that was related to body weight loss
- was released after injection of tumor-activated macrophages
- these macrophages released TNF-alpha
- Host-tumor response
- was released after injection of tumor-activated macrophages
How do TUMORS cause CAC?
- @Tissue level, tumors have:
- tumor cells
- cancer associated Fibroblast
-
Immune cells
- -> secrete a variety of cytokines SYSTEMICALLY
-
Alter metabolism everywhere
- –> CACHEXIA
-
Alter metabolism everywhere
- -> secrete a variety of cytokines SYSTEMICALLY
What represents the main predictor of mortality?
-
Weight Loss from Cachexia
-
Multi-factoral, caused by:
- Reduced food intake
- systemic metabolic dysfunction
- INCREASE in Energy expenditure
-
Multi-factoral, caused by:
What causes WEIGHT LOSS in cancer?
Reduced food intake
systemic metabolic dysfunction
INCREASE in Energy expenditure
-
Experiment: injecting TNF-Alpha or IL6 in mice
- Caused weight loss
-
but the same number of cancer cells did NOT
- _ultimately it’s the response that causes weight loss / cachexia_
How does Cancer cause CACHEXIA?
- Absorptive Disorders
-
Reduced Intake
- Cancer treatments -> Anorexia
- decrease in physical activity & mechanical obstacles
-
Metabolic Disturbances
-
Host/tumor competitions + Tumor side products:
- Inadequation
- Metabolism
-
Host/tumor competitions + Tumor side products:
CAC & Glucose metabolism
- Glucose levels clear FASTER
- Glucose production is also INCREASED due to:
-
Cori Cycle
-
Lactate Dehydrogenase (LDH) is massively INCREASED
- in liver:
- pyruvate –> LACTATE excess
- in liver:
-
Lactate Dehydrogenase (LDH) is massively INCREASED
-
Cori Cycle
CAC & Lipolysis
- Tumor secreting:
- TNF-alpha
- IL6
-
Prostaglandins
-
–> I_NCREASED LIPOLYSIS_
- in Adipose, TG’s -> FFA’s + Glycerol
-
–> I_NCREASED LIPOLYSIS_
CAC & Adipocytes
- Change in mitochondrial content:
- WAT -> Brown Adipose
- PROMOTES Energy Expenditure
- Body weight loss
- WAT -> Brown Adipose
- Browning occurs before the loss of skeletal mass
How does WAT Browning Occur?
-
IL-6 + PTHrP (parathyroid hormone related protein)
-
induces changes in UCP1
-
–> INCREASE in Mitochondrial Content
- decreased lipogenesis
- Increased Lipolysis
- WAT –> BROWN ADIPOCYTES
-
–> INCREASE in Mitochondrial Content
-
induces changes in UCP1
What does Brown Adipocytes do to the body?
- BAT’s go from energy storage –> PRODUCTION OF HEAT
-
@Tissue level
-
Increase in Lipolysis
- TG’s -> FFA + Glycerol
-
Increase in Lipolysis
- @Organismal Level
- DANGEROUS REDUCTION IN BODY WEIGHT
-
@Tissue level
IL-6 & PTHrP
- Secreted from TUMOR
- -> WAT
- Beta adrenergic activation
-
Change UCP1 -> CHANGE IN MITO ACTIVITY
- -> more LIPOLYSIS
- -> THERMOGENESIS
- -> CACHEXIA
-
Change UCP1 -> CHANGE IN MITO ACTIVITY
- Beta adrenergic activation
- -> WAT
How does CAC cause Muscle Atrophy?
- The TGF-Beta superfamily members:
-
Myostatin + Activin
- -> signal ACTR2B (activin type 2 receptor - B)
- ATROPHY OF MUSCLES (including heart)
- -> signal ACTR2B (activin type 2 receptor - B)
-
Myostatin + Activin
Myostatin and Activin
TGF-Beta superfamily members
Signal ACTR2B
and cause MUSCLE ATROPHY
ARE OVERACTIVE IN CAC PATIENTS
What does the BLOCKADE of ACTR2B cause?
- Reduce Muscle Atrophy*
- Prevents Atrophy of Cardiac Muscle*
Positive influence on Insulin Resistance
& Systemic Inflammation
Tested on MICE
What does a ACTR2B INHIBITOR do?
-
Negatively influences Myostatin + Activin
-
so they do not activate ACTR2B
- -> Hypertrophy signals occur –> Build Muscle
- Atrophy is lessened
- -> Hypertrophy signals occur –> Build Muscle
-
so they do not activate ACTR2B
How does a ACTR2B ANTAGNIST affect OBESITY?
- ACTR2B Antagonist –> HYPERTROPHY = MORE MUSCLE
- -> Less Fat
- -> More glucose uptake
- -> More Insulin sensitivity
How does CAC affect the LIVER?
-
Activated Macrophages in liver produce IL6
-
Reduction in Hepatic Oxidation
- Increase in ROS
- Energy Wasting
- Increase in Hepatic Gluconeogenesis
-
Reduction in Hepatic Oxidation
How CAC affects each organ’s metabolism
- Tumor secretes: TNF-alpha + IL6/1 -> Systemic Inflammation
- Tumor + Cytokines -> Anorexia
-
Adipocytes
- WAT -> BAT
- increase in THERMOGENESIS / LIPOLYSIS
- WAT -> BAT
-
Liver
- reduction in drug clearance (less oxidation)
- -> increase in TOXICITY
- reduction in drug clearance (less oxidation)
- Muscle Wasting
- Adipocyte Depletion
Ghrelin for CAC
- Beneficial Effect on WEIGHT GAIN (from increased APPITITE)
- +No effect on tumor growth
- ANAMORELIN
Anamorelin
- Non-peptide, orally active Ghrelin Receptor Agonist
- Romana 1 / 2 trials showed this in non-small cell lung cancer:
- increase in Lean Body Mass
- good for CAC’s weight loss issue
-
no increase in Handgrip strength
- **to see if Anemorelin also helped with CAC’s **muscle wasting
- increase in Lean Body Mass
Possible Treatments for CAC
INHIBIN AGONIST (inhibit ACTR2B)
Ghrelin Receptor Agonist
ACTR2B Antagonist
Anti-inflammatories
Hormones